Calliditas Therapeutics AB (publ) (CALT)
NASDAQ: CALT · IEX Real-Time Price · USD
18.08
-0.62 (-3.30%)
At close: Apr 22, 2024, 4:00 PM
18.27
+0.19 (1.04%)
After-hours: Apr 22, 2024, 4:00 PM EDT

CALT Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Year 20222021202020192018
Net Income
-412.27-500.29-433.49-32.58-132.05
Other Operating Activities
100.9138.71124.31-38.433.86
Operating Cash Flow
-311.35-461.59-309.18-71.01-128.19
Capital Expenditures
0-6.590-0.120
Acquisitions
00-172.600
Change in Investments
-2.63-1.69-0.01-1.890
Other Investing Activities
-2.51-16.07--16.07-
Investing Cash Flow
-5.14-24.34-172.61-18.070
Share Issuance / Repurchase
0303.09795.45197.65714.22
Debt Issued / Paid
480.87179.09-3.97-1.65-0.47
Other Financing Activities
95.12-47.02-22.922.832.83
Financing Cash Flow
575.99435.16768.56198.84716.57
Net Cash Flow
259.49-50.77286.77109.75588.38
Free Cash Flow
-311.35-468.18-309.18-71.13-128.19
Free Cash Flow Margin
-38.78%-204.13%-35375.40%-38.48%-
Free Cash Flow Per Share
-10.54-18.75-13.36-3.07-
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).